Alzheimer’s drug rejected for NHS use uptrends.live
A new Alzheimer’s drug has been rejected for widespread use in health services in England after the health spending watchdog said it “currently demonstrates no value to the NHS”. The news comes as the UK’s medicines regulator said donanemab could be authorized for use in the UK. This is the second disease-modifying drug for Alzheimer’s … Read more